synbiobeta highlights – Bugs Making Drugs

… Arzeda
, which earlier signed an agreement to create novel seeds with DuPont, has turned its platform technology to creating specialty chemicals and pharma intermediates. Alex Zanghellini, the CEO will discuss the company’s journey thus far.